Last reviewed · How we verify

NCT05115968

Single Cell Sequencing of Tonsillar Tissue in Children With OSA

Recruiting now Last updated 13 February 2025
What this trial tests

trial testing Tonsillectomy in Obstructive Sleep Apnea of Child in 15 participants. Currently enrolling.

Timeline
1 January 2023
Primary endpoint
31 December 2025
31 December 2025

Quick facts

Lead sponsorChinese University of Hong Kong
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment15
Start date1 January 2023
Primary completion31 December 2025
Estimated completion31 December 2025
Sites1 location across Hong Kong

Drugs / interventions tested

Conditions studied

Sponsor

Chinese University of Hong Kong

Who can join

Adults 6 to 11, any sex, with Obstructive Sleep Apnea of Child. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Obstructive sleep apnoea (OSA) in children is a prevalent sleep disorder, and is characterised by repetitive complete or partial upper airway obstruction during sleep. It is an important disease as it is associated with a large spectrum of end-organ morbidities. Adenotonsillar hypertrophy is the commonest cause of OSA in children, however, the cause of the lymphoid tissue hypertrophy in some individuals but not the others remains unknown. To address the cellular heterogeneity and immune cell involvement in adenotonsillar hypertrophy, here, we propose to employ single-cell sequencing analysis to identify the cell-specific expression patterns associated with the disease, which will enhance our understanding of the pathogenesis of tonsillar hypertrophy in children with OSA and may provide directions for development of novel therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Tonsillectomy

Trials testing the same drug.

Other recruiting trials for Obstructive Sleep Apnea of Child

Currently open trials in the same condition.

Other Chinese University of Hong Kong trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05115968.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing